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Amniotic fluid (AF) contains stem cells which, due to their ontogenetic origin, have a high 
proliferative and differentiative potential and might be an attractive source of multipotent stem cells 
for therapeutic transplantation. We studied the phenotypic characteristics, differentiation potential 
and immunomodulation proprieties in vitro of mesenchymal stem cells (MSCs) isolated from 
human amniotic fluid (AF), during routine prenatal amniocentesis, and evaluated their compared to 
bone marrow (BM) MSCs. 
We isolated multi-potent stem cells from AF that showed a high proliferative potential, were 
positive for CD90, CD105, CD29, CD44, CD73, CD166; showed Oct-4 and Nanog molecular and 
protein expression and differentiated into osteoblasts, adypocytes and chondrocytes. In Neural 
Progenitor Mantainance Medium (NPMM) AF-MSCs expressed neural markers and increased Na+ 
channel density. Inactivation of the TTX-sensitive channels accelerated and became more similar to 
native neuronal voltage-gated Na+ channels.  
We investigated the beneficial immunomodulatory effects of MSCs in co-cultures with different 
immunogenic populations such as Dendritic Cells (DCs) and regulatory CD4+ CD25+ T cells.  
MSCs strongly inhibit the differentiation of monocytes to DCs and there was a significant reduction 
in the expression of CD83 mature DCs treated with MSCs, suggesting their skew to immature 
status. A decreased expression of presentation molecules (HLA-DR) and co-stimulatory molecules 
(CD80 and CD86) were also observed. 
CD4+CD25+ regulatory T cells significantly increase in presence of MSCs. In the control group 
there is 5.5% of CD4+CD25+ T cells, 23.4% in co-culture with AF-derived MSCs, and 16% in co-
culture with BM-derived MSCs. 
These data suggest that AF-MSCs have a stronger immunosuppressive effect compared to BM-
MSCs. This interesting aspect can be easily due to the more premature stemness stage of the AF-
MSCs rather than BM-MSCs. We hypothesise that MSCs have proliferative, differentiative and 
immunological characteristics more similar to AF-MSCs than to BM-MSCs. 
AF is an important multipotent stem cell source with a high proliferative potential able to originate 
potential precursors of functional neurons and showed a stronger immunosuppressive effect 
compared to BM-derived MSCs. This effect was mediated by inducing the generation of 
CD4+CD25+ regulatory cells and by suppressing monocyte differentiation into DCs, thus 
indicating the important role of AF-MSCs on immunoregulation 
